glp-1 drugs thyroid cancer Implications of Receptor Agonist on Function: A Literature Review of Its Effects on Thyroid Volume, Risk of Cancer, Functionality and TSH Levels Frontiers | Drug repositioning in

Description

& McMurray, J

Because rodents have a higher density of GLP-1 receptors in thyroid C-cells, regulators issued boxed warnings about potential medullary thyroid carcinoma risk

This faster titration timeline partly explains why retatrutide achieves greater weight loss in shorter study durations

Others expressed potential concerns about the speedy review timeline, however

Yki-Jarvinen H

In this blog post we will debunk some of the most common myths associated with GLP-1 agonists for weight loss, providing clarity and insight into how these treatments really work